Published in Biochim Biophys Acta on November 15, 2005
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell (2010) 4.07
Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep (2012) 2.76
Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res (2008) 2.70
Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal (2009) 2.27
Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res (2009) 1.77
Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer (2006) 1.65
Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis. Int J Mol Sci (2013) 1.28
Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions. Cancer Res (2008) 1.24
TERRA transcripts are bound by a complex array of RNA-binding proteins. Nat Commun (2010) 1.19
hnRNP A1: the Swiss army knife of gene expression. Int J Mol Sci (2013) 1.19
Translation arrest and ribonomics in post-ischemic brain: layers and layers of players. J Neurochem (2008) 1.10
Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. J Biol Chem (2012) 1.08
Quantitative analysis of brain nuclear phosphoproteins identifies developmentally regulated phosphorylation events. J Proteome Res (2008) 1.08
Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues. BMC Cancer (2010) 1.05
Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53. Int J Cancer (2010) 1.04
HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition. Nucleic Acids Res (2013) 1.00
DNA double-strand breaks coupled with PARP1 and HNRNPA2B1 binding sites flank coordinately expressed domains in human chromosomes. PLoS Genet (2013) 0.98
A glycine-rich domain of hnRNP H/F promotes nucleocytoplasmic shuttling and nuclear import through an interaction with transportin 1. Mol Cell Biol (2010) 0.98
Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M. J Biol Chem (2011) 0.97
Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. Br J Cancer (2009) 0.96
Hormone response element binding proteins: novel regulators of vitamin D and estrogen signaling. Steroids (2011) 0.95
Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma. Br J Cancer (2007) 0.95
Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics (2007) 0.93
c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway. Cancer Res (2011) 0.93
Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ. PLoS One (2011) 0.93
The role of hnRPUL1 involved in DNA damage response is related to PARP1. PLoS One (2013) 0.92
Involvement of heterogeneous ribonucleoprotein F in the regulation of cell proliferation via the mammalian target of rapamycin/S6 kinase 2 pathway. J Biol Chem (2010) 0.92
The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis. J Med Chem (2014) 0.90
Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver. Clin Exp Metastasis (2011) 0.88
Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein. J Biol Chem (2009) 0.87
Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma. BMC Cancer (2010) 0.86
Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients. Br J Cancer (2006) 0.85
Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture. Proteomics (2010) 0.85
Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site. J Biol Chem (2008) 0.82
Emerging roles for hnRNPs in post-transcriptional regulation: what can we learn from flies? Chromosoma (2014) 0.82
A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression. Proteome Sci (2015) 0.82
Label-free LC-MS analysis of HER2+ breast cancer cell line response to HER2 inhibitor treatment. Daru (2015) 0.81
The heterodimeric structure of heterogeneous nuclear ribonucleoprotein C1/C2 dictates 1,25-dihydroxyvitamin D-directed transcriptional events in osteoblasts. Bone Res (2014) 0.81
Lin28 induces resistance to anti-androgens via promotion of AR splice variant generation. Prostate (2015) 0.81
BRCA1 modulates the expression of hnRNPA2B1 and KHSRP. Cell Cycle (2010) 0.80
Acetylome Analysis Identifies SIRT1 Targets in mRNA-Processing and Chromatin-Remodeling in Mouse Liver. PLoS One (2015) 0.79
Analysis of protein expression profiles in the thymus of chickens infected with Marek's disease virus. Virol J (2012) 0.79
Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells. Oncotarget (2015) 0.78
Sqd interacts with the Drosophila retinoblastoma tumor suppressor Rbf. Biochem Biophys Res Commun (2009) 0.78
Expression and mutation analysis of heterogeneous nuclear ribonucleoprotein G in human oral cancer. Oral Oncol (2011) 0.78
Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis. J Hematol Oncol (2012) 0.77
Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis. Int J Mol Sci (2016) 0.77
Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21). Clin Proteomics (2014) 0.77
Downregulation of hnRNP K by RNAi inhibits growth of human lung carcinoma cells. Oncol Lett (2014) 0.77
RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK. Oncotarget (2015) 0.76
Downregulated Poly-C binding protein-1 is a novel predictor associated with poor prognosis in Acute Myeloid Leukemia. Diagn Pathol (2015) 0.76
Replication error deficient and proficient colorectal cancer gene expression differences caused by 3'UTR polyT sequence deletions. Proc Natl Acad Sci U S A (2010) 0.76
Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells. Invest New Drugs (2010) 0.76
Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression. Oncotarget (2015) 0.76
Functions of heterogeneous nuclear ribonucleoproteins in stem cell potency and differentiation. Biomed Res Int (2013) 0.76
Role and molecular mechanism of heterogeneous nuclear ribonucleoprotein K in tumor development and progression. Biomed Rep (2016) 0.75
Nuclear distribution of eIF3g and its interacting nuclear proteins in breast cancer cells. Mol Med Rep (2016) 0.75
The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression. Mol Cell Oncol (2014) 0.75
Proteomic analysis of testicular ischemia-reperfusion injury in rats. J Vet Med Sci (2013) 0.75
Novel insight into the composition of human single-stranded DNA-binding protein 1 (hSSB1)-containing protein complexes. BMC Mol Biol (2016) 0.75
Metformin treatment reduces temozolomide resistance of glioblastoma cells. Oncotarget (2016) 0.75
The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer. PLoS One (2017) 0.75
Novel oligosaccharide has suppressive activity against human leukemia cell proliferation. Glycoconj J (2008) 0.75
Transcriptomic Analysis of Male Black Tiger Shrimp (Penaeus monodon) After Polychaete Feeding to Enhance Testicular Maturation. Mar Biotechnol (NY) (2017) 0.75
ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell (2013) 2.32
Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol Cancer Ther (2004) 2.20
Current and emerging concepts in tumour metastasis. J Pathol (2010) 1.88
The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol (2002) 1.78
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol (2006) 1.67
The inflammatory microenvironment in colorectal neoplasia. PLoS One (2011) 1.62
Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol (2005) 1.53
Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res (2004) 1.36
The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. J Natl Cancer Inst (2011) 1.34
New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol (2003) 1.31
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res (2004) 1.29
Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog (2013) 1.27
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res (2005) 1.25
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res (2005) 1.22
Profiling markers of prognosis in colorectal cancer. Clin Cancer Res (2006) 1.17
Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol (2002) 1.17
Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem J (2005) 1.11
Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS One (2011) 1.08
Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue. Int J Radiat Oncol Biol Phys (2004) 1.08
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res (2012) 1.02
The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum Pathol (2010) 1.01
The candidate oncogene ZNF217 is frequently amplified in colon cancer. J Pathol (2004) 1.01
The proteomics of colorectal cancer: identification of a protein signature associated with prognosis. PLoS One (2011) 1.00
Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer. J Clin Oncol (2006) 0.99
Cytochrome P450 1B1: a novel anticancer therapeutic target. Future Oncol (2005) 0.97
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling. BMC Cancer (2009) 0.94
Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect Immun (2012) 0.93
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Histopathology (2009) 0.92
Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Hum Pathol (2002) 0.90
Identification and characterization of the transcription factors involved in T-cell development, t-bet, stat6 and foxp3, within the zebrafish, Danio rerio. FEBS J (2009) 0.89
The use of formalin fixed wax embedded tissue for proteomic analysis. J Clin Pathol (2011) 0.89
CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia. Oncol Rep (2002) 0.88
Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients. Histopathology (2013) 0.88
Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity. Cell Microbiol (2014) 0.86
Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia. Saudi Med J (2004) 0.85
Laser capture microdissection and PCR for analysis of human papilloma virus infection. Methods Mol Biol (2005) 0.84
Biomarkers of colorectal cancer: recent advances and future challenges. Proteomics Clin Appl (2015) 0.84
Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation. Gut (2013) 0.84
Discovery of zebrafish (Danio rerio) interleukin-23 alpha (IL-23α) chain, a subunit important for the formation of IL-23, a cytokine involved in the development of Th17 cells and inflammation. Mol Immunol (2011) 0.84
Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study. BMC Res Notes (2012) 0.83
Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer. J Pathol (2012) 0.83
Isolated tuberculosis of the liver: a diagnostic challenge. BMJ Case Rep (2011) 0.83
Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis. Oncol Rep (2002) 0.83
Progress in the identification of plasma biomarkers of colorectal cancer. Proteomics (2013) 0.83
Quantitative analysis of the Ah receptor/cytochrome P450 CYP1B1/CYP1A1 signalling pathway. Biochem Pharmacol (2003) 0.81
Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res (2007) 0.81
The proteomics of formalin-fixed wax-embedded tissue. Clin Biochem (2012) 0.80
Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma. J Pathol (2004) 0.80
Molecular cloning and characterization of interferon regulatory factors 4 and 8 (IRF-4 and IRF-8) in rainbow trout, Oncorhynchus mykiss. Fish Shellfish Immunol (2010) 0.79
Cytochrome P450 enzymes and tumor therapy. Mol Cancer Ther (2004) 0.78
The role of gene regulatory networks in promoting cancer progression and metastasis. Future Oncol (2014) 0.76
An introduction to laser-based tissue microdissection techniques. Methods Mol Biol (2005) 0.76
Correction: First Demonstration of Antigen Induced Cytokine Expression by CD4-1+ Lymphocytes in a Poikilotherm: Studies in Zebrafish (Danio rerio). PLoS One (2016) 0.75
Has the proteome of formalin-fixed wax-embedded tissue been unlocked? Nephrol Dial Transplant (2012) 0.75
Familial collagenous colitis involving a 6-year old child. J Crohns Colitis (2011) 0.75
Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia. Ann Saudi Med (2004) 0.75
The Journal of Pathology 2008 Jeremy Jass Prize for Research Excellence in Pathology. J Pathol (2009) 0.75